Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 240 for “"Pre-eclampsia"”.

  1. Screening Programme for Pre-eclampsia

    Background <br/>Pre-eclampsia (PE) is a hypertensive disorder complicating 2–8% of all pregnancies and is a major cause of perinatal morbidity and mortality. The majority of women with PE present clinically near term with favourable maternal and neonatal outcomes; however, a subset of women …

    kings Repository record for Screening Programme for Pre-eclampsia (opens in a new tab) Download PDF for Screening Programme for Pre-eclampsia (opens in a new tab)

  2. Inflammatory Mediators Associated with Pre-eclampsia

    PURPOSE: Pre-eclampsia, a hypertensive disorder unique in pregnancy, complicates approximately 5-7 % of pregnancies and is a leading cause of intrauterine fetal growth retardation, premature delivery, and maternal death. It is characterized by proteinuria, edema, platelet aggregation, and increased …

    ajou Repository record for Inflammatory Mediators Associated with Pre-eclampsia (opens in a new tab) Embargoed until 9999-12-31

  3. The PIERS (Pre-eclampsia Integrated Estimate of RiSk) model : development of a valid outcome prediction model for pre-eclampsia.

    … of maternal risk by developing a model - the Pre-eclampsia Integrated Estimate of RiSk (or PIERS) model – that predicts a combined adverse maternal outcome (mortality and/or significant morbidities) within 48 hour of, and up to seven days after, admission with pre-eclampsia (study …

    ubc Repository record for The PIERS (Pre-eclampsia Integrated Estimate of RiSk) model : development of a valid outcome prediction model for pre-eclampsia. (opens in a new tab) Download PDF for The PIERS (Pre-eclampsia Integrated Estimate of RiSk) model : development of a valid outcome prediction model for pre-eclampsia. (opens in a new tab)

  4. Genetic determinants of pre-eclampsia: HLA-G and KIR2DL4 alleles/haplotypes and risk of pre-eclampsia in a malay population

    Pre-eclampsia (PE) is a leading cause of maternal and fetal mortality andmorbidity. HLA-G is expressed predominantly on fetal extravillous trophoblasts thatinvade the maternal decidua during pregnancy and has been postulated to beimportant in the maintenance of a healthy pregnancy. It has been …

    nus Repository record for Genetic determinants of pre-eclampsia: HLA-G and KIR2DL4 alleles/haplotypes and risk of pre-eclampsia in a malay population (opens in a new tab) Download file for Genetic determinants of pre-eclampsia: HLA-G and KIR2DL4 alleles/haplotypes and risk of pre-eclampsia in a malay population (opens in a new tab)

  5. The role of nitric oxide in pre-eclampsia

    Hypertension complicates approximately 10% of all pregnancies and is a leading cause of maternal and foetal mortality and morbidity world-wide. Pre-eclampsia is a major subgroup of these hypertensive disorders. It is defined as a rise in blood pressure to 140/90mm Hg or greater accompanied by …

    sheffield-hallam Download file for The role of nitric oxide in pre-eclampsia (opens in a new tab)

  6. Pre-eclampsia: early prediction and long-term consequences

    Approximately one in ten pregnant women will have their blood pressure recorded above normal at some point during their pregnancy. Pre-eclampsia, the most common hypertensive disorder of pregnancy, affects around 5% of all first time mothers, and is an important cause of foetal and maternal …

    glasgow Download PDF for Pre-eclampsia: early prediction and long-term consequences (opens in a new tab)

  7. A study of coagulation potential in pre-eclampsia

    Pre-eclampsia is a multisystem obstetric disease of unknown aetiology that is associated with enhanced coagulation, endothelial activation and reduced placental function. A two-stage model for pre-eclampsia has been proposed involving abnormal placentation and the maternal response to this. In this …

    glasgow Download PDF for A study of coagulation potential in pre-eclampsia (opens in a new tab)

  8. Validity of Administrative Database for Reporting Pre-eclampsia

    Background: Pre-eclampsia (PET) is one of the major causes of maternal and neonatal morbidity and mortality1. Misclassification of PET can lead to biased or erroneous results in epidemiologic studies resulting in false conclusions. Objectives: The objectives of this thesis are to determine the …

    ottawa-retro Repository record for Validity of Administrative Database for Reporting Pre-eclampsia (opens in a new tab)

  9. The prediction of adverse maternal outcomes in pre-eclampsia

    Pre-eclampsia (PET) continues to contribute to maternal and perinatal morbidity and mortality. Management decisions include an evaluation of maternal risk, which is assisted by expert opinion-based guidelines, while not accounting for gestational age (GA) at diagnosis. We evaluated the feasibility …

    ubc Repository record for The prediction of adverse maternal outcomes in pre-eclampsia (opens in a new tab) Download PDF for The prediction of adverse maternal outcomes in pre-eclampsia (opens in a new tab)

  10. The maternal predisposition to the syndrome of pre-eclampsia

    Pre-eclampsia, which is characterized by maternal hypertension, proteinuria, hypoperfusion of end organs and a systemic maternal innate inflammatory response, is a leading cause of maternal mortality and morbidity world-wide. When of early-onset, pre-eclampsia is associated with fetal intrauterine …

    ubc Repository record for The maternal predisposition to the syndrome of pre-eclampsia (opens in a new tab) Download PDF for The maternal predisposition to the syndrome of pre-eclampsia (opens in a new tab)

  11. Markers of Cardiovascular Dysfunction After Pregnancies Complicated by Pre-Eclampsia

    Pre-eclampsia (PE) is a hypertensive disorder of pregnancy characterized by maternal systemic endothelial dysfunction. While the clinical manifestations resolve soon after delivery, a large body of epidemiological evidence indicates significant long-term maternal risk for cardiovascular disease …

    queens Repository record for Markers of Cardiovascular Dysfunction After Pregnancies Complicated by Pre-Eclampsia (opens in a new tab)

  12. Vascular damage in pre-eclampsia: the role of endothelial dysfunction

    Pre-eclampsia is a multisystem disorder specific to pregnant women and is the major cause of maternal death in the United Kingdom today. The common pathophysiological feature of virtually all manifestations of pre-eclampsia is vascular endothelial dysfunction. This probably results from poor …

    glasgow Repository record for Vascular damage in pre-eclampsia: the role of endothelial dysfunction (opens in a new tab) Download PDF for Vascular damage in pre-eclampsia: the role of endothelial dysfunction (opens in a new tab)

  13. The role of the paraoxonases in pre-eclampsia and labour

    … labour, the hypothesis was that placental PON2 expression would alter during labour. PON2 was examined in placentas obtained from women who delivered by caesarean section and were not in labour and compared to the equivalent zone of placentas obtained from women who delivered vaginally following …

    glasgow Download PDF for The role of the paraoxonases in pre-eclampsia and labour (opens in a new tab)

  14. Quantification of the glycocalyx in the study of pre-eclampsia

    Introduction: Pre-eclampsia is a multisystem disorder of pregnancy characterised by widespread endothelial dysfunction. The glycocalyx is present at the luminal surface of endothelial cells and at the maternal-fetal interface of the placenta. It has important roles in maintaining normal endothelial …

    bristol Repository record for Quantification of the glycocalyx in the study of pre-eclampsia (opens in a new tab) Download PDF for Quantification of the glycocalyx in the study of pre-eclampsia (opens in a new tab)

  15. Vascular biology in the menstrual cycle, pregnancy and pre-eclampsia

    … causes of maternal death in the United Kingdom. Pre-eclampsia is associated with increase in immediate and lifetime risk of adverse thrombotic events. Both pregnancy and the follicular phase are associated with arterial thrombosis and myocardial infarction. Modulation of haemostatic mechanisms in …

    edinburgh Repository record for Vascular biology in the menstrual cycle, pregnancy and pre-eclampsia (opens in a new tab)

  16. Epidemiological and genetic approaches to explore risk factors for pre-eclampsia

    Problem: Pre-eclampsia (PE) is a pregnancy complication that occurs in 3-10% of pregnancies world-wide, and it is characterized by high blood pressure and proteinuria. HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelets syndrome) is a form of severe PE. Both environmental and genetic …

    ubc Repository record for Epidemiological and genetic approaches to explore risk factors for pre-eclampsia (opens in a new tab) Download PDF for Epidemiological and genetic approaches to explore risk factors for pre-eclampsia (opens in a new tab)

  17. Recombinant human activated protein C as a therapy for pre-eclampsia

    INTRODUCTION: Pre-eclampsia remains one of the most common causes of maternal mortality in the developed world, and we still have no known effective prophylaxis and proven modifiers. The recent successful clinical trial of recombinant human activated protein C (rhAPC) in the management of SIRS …

    ubc Repository record for Recombinant human activated protein C as a therapy for pre-eclampsia (opens in a new tab) Download PDF for Recombinant human activated protein C as a therapy for pre-eclampsia (opens in a new tab)

Page 1 of 12